Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Clinical trial NCT00910520 · COMPLETED

Trial details

NCT number: NCT00910520
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2009-09-01
Primary completion: 2011-08-01
Enrollment: 548

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.